Dal Pero F - Search Results

1

Evidence for sequence selection within the non-structural 5A gene of hepatitis C virus type 1b during unsuccessful treatment with interferon-alpha.

Gerotto M, Dal Pero F, Sullivan DG, Chemello L, Cavalletto L, Polyak SJ, Pontisso P, Gretch DR, Alberti A. Gerotto M, et al. Among authors: dal pero f. J Viral Hepat. 1999 Sep;6(5):367-72. doi: 10.1046/j.1365-2893.1999.00166.x. J Viral Hepat. 1999. PMID: 10607252

2

Two PKR inhibitor HCV proteins correlate with early but not sustained response to interferon.

Gerotto M, Dal Pero F, Pontisso P, Noventa F, Gatta A, Alberti A. Gerotto M, et al. Among authors: dal pero f. Gastroenterology. 2000 Dec;119(6):1649-55. doi: 10.1053/gast.2000.20230. Gastroenterology. 2000. PMID: 11113086

3

Detailed analysis of the E2-IgM complex in hepatitis C-related type II mixed cryoglobulinaemia.

Ferri S, Dal Pero F, Bortoletto G, Bianchi FB, Lenzi M, Alberti A, Gerotto M. Ferri S, et al. Among authors: dal pero f. J Viral Hepat. 2006 Mar;13(3):166-76. doi: 10.1111/j.1365-2893.2005.00675.x. J Viral Hepat. 2006. PMID: 16475992

4

PKR gene expression and response to pegylated interferon plus ribavirin therapy in chronic hepatitis C.

Gerotto M, Dal Pero F, Bortoletto G, Realdon S, Ferrari A, Boccato S, Alberti A. Gerotto M, et al. Among authors: dal pero f. Antivir Ther. 2004 Oct;9(5):763-70. Antivir Ther. 2004. PMID: 15535414

5

Hepatitis C minimal residual viremia (MRV) detected by TMA at the end of Peg-IFN plus ribavirin therapy predicts post-treatment relapse.

Gerotto M, Dal Pero F, Bortoletto G, Ferrari A, Pistis R, Sebastiani G, Fagiuoli S, Realdon S, Alberti A. Gerotto M, et al. Among authors: dal pero f. J Hepatol. 2006 Jan;44(1):83-7. doi: 10.1016/j.jhep.2005.08.016. Epub 2005 Sep 21. J Hepatol. 2006. PMID: 16271794

6

Impact of NS5A sequences of Hepatitis C virus genotype 1a on early viral kinetics during treatment with peginterferon- alpha 2a plus ribavirin.

Dal Pero F, Tang KH, Gerotto M, Bortoletto G, Paulon E, Herrmann E, Zeuzem S, Alberti A, Naoumov NV. Dal Pero F, et al. J Infect Dis. 2007 Oct 1;196(7):998-1005. doi: 10.1086/521306. Epub 2007 Aug 21. J Infect Dis. 2007. PMID: 17763320 Clinical Trial.

7

A 385 insertion in the hypervariable region 1 of hepatitis C virus E2 envelope protein is found in some patients with mixed cryoglobulinemia type 2.

Gerotto M, Dal Pero F, Loffreda S, Bianchi FB, Alberti A, Lenzi M. Gerotto M, et al. Among authors: dal pero f. Blood. 2001 Nov 1;98(9):2657-63. doi: 10.1182/blood.v98.9.2657. Blood. 2001. PMID: 11675335 Free article.

8

Evolution of hepatitis C virus quasispecies in children with chronic hepatitis C.

Gerotto M, Resti M, Dal Pero F, Migliorato I, Alberti A, Bortolotti F. Gerotto M, et al. Among authors: dal pero f. Infection. 2006 Apr;34(2):62-5. doi: 10.1007/s15010-006-5037-4. Infection. 2006. PMID: 16703294

9

Heterogeneity of CK2 phosphorylation sites in the NS5A protein of different hepatitis C virus genotypes.

Dal Pero F, Di Maira G, Marin O, Bortoletto G, Pinna LA, Alberti A, Ruzzene M, Gerotto M. Dal Pero F, et al. J Hepatol. 2007 Dec;47(6):768-76. doi: 10.1016/j.jhep.2007.07.020. Epub 2007 Sep 24. J Hepatol. 2007. PMID: 17923166

10

Proapoptotic effect of hepatitis C virus CORE protein in transiently transfected cells is enhanced by nuclear localization and is dependent on PKR activation.

Realdon S, Gerotto M, Dal Pero F, Marin O, Granato A, Basso G, Muraca M, Alberti A. Realdon S, et al. Among authors: dal pero f. J Hepatol. 2004 Jan;40(1):77-85. doi: 10.1016/j.jhep.2003.09.017. J Hepatol. 2004. PMID: 14672617

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters